Avantyo Newsletter My account Podcast Search Calendar
Next: Clinical Trials for Study Coordinators on February 1st & 2nd, 2024

INTENSIVE STUDY NURSE TRAINING

Schedule

Registration closed

Find out about the next training date!

Login / register to subscribe

The study team at the clinical site has many actors: principal investigator, sub-investigators, study coordinators, study nurses etc.

The Clinical Research Nurse, under the guidance and supervision of the Principal Investigator (PI), ensures that the clinical trials are conducted following the study protocol. This position is primarily responsible for the accurate completion of visit procedures and collection of information from the patients participating in the study according to protocols to protect the health, safety and welfare of research participants. In some particular cases, the study nurse may act as the study coordinator.

AIM: to prepare properly study nurses for their participation in clinical trials developed in Romania.

METHOD: Different physicians, clinicians or laboratory specialists, playing the role of participating in CT as investigators and clinical research logistics coordinators are speakers for this project.

Nurses would have the possibility to put the knowledge in practice (1 day of practical exercise in a phase I unit and a lab).


Organizers: AVANTYO  - Institute of Clinical Research 

Location: Online

Trainer:   Dr. Cristina Florescu Moraid, Dr. Delia Codruta Popa, Dr. Livadariu Mirela & Dr. Patru Loredana Florina


Attendance only by online reservation. Booking available after registering on this site.

For discounts and assistance please contact us:

info@avantyo.com

diana.lupu@avantyo.com (0726 840 456)


If you would like to be placed on a waiting list for the next course or you need something else, please let us know at info@avantyo.com. Do not forget to mention your specific education needs in clinical trials.

Privacy Policy & GDPR

The intended candidates for this program are individuals with a general or laboratory medicine background, working as generalists or laboratory nurses in public or private hospitals, clinics, or GP cabinets. These participants should be enthusiastic about taking on the role of study nurses in clinical trials or have prior experience in clinical studies and a strong willingness to deepen their knowledge further.

Dr. Cristina Florescu Moraid President of Clinical Trials Symposium, CEO AVANTYO Institute of Clinical Research
  • Dr. Florescu Moraid got her Medical Doctor Diploma in 1998 from „Carol Davila” University of Medicine and Pharmacy in Bucharest, Romania and was accredited as Laboratory Medicine Specialist in 2005 and as Senior Laboratory Medicine Specialist in 2011, by the Romanian College of Physicians.
  • She got her Master of Science Diploma in 2006 , accomplished Postgraduated School of Clinical Trials Management, Gdansk in 2012 and the Postgraduated Leadership Development Programme at University of Sussex, UK in 2014.
  • Dr. Florescu Moraid was responsible for clinical trials operations at Synevo Central Lab, the clinical research wing of Swedish Medicover Group as Regional Director for Romania, Moldova, Bulgaria and Serbia between 2005-2018. She has been organizing Synevo Clinical Trials Symposium for 10 years.
  • Since beginning of 2019, she is Co-founder of Avantyo - Institute of Clinical Research and CEO of Camina Medical Experts, developing tailored CT services for pharma sponsors, CROs and mid-size biotech companies.
  • She is invited speaker for different scientific events and acts as active advocate for rising awareness over the importance of developing clinical trials for the patient’s benefit.
Dr. Delia Codruta Popa Primary physician in Laboratory medicine and coordinator of the Hematological Analysis laboratory ,Fundeni Clinical Institute, Bucharest
  • Primary physician in Laboratory medicine and coordinator of the Hematological Analysis laboratory within the Fundeni Clinical Institute, Bucharest.
  • Doctor of Medicine from 2015, title of the doctoral thesis: Evaluation of circulating HCV genotypes in Romania, Head of Work at the Department of Biochemistry of the Carol Davila University of Medicine and Pharmacy, Bucharest.
  • Participation in educational and continuous training projects:
  • 2006-2008, CEEX 158/2006, "Investigation of molecular mechanisms from the HCV genome with implications for the development of diagnostic and therapeutic systems;
  • 2008-2010, Project financed by the European Commission, Public Health Programme, DG SANCO, and SUNFLOWER: "Young and HIV: A European Network to Arrange an Innovative Prevention Campaign and to Exchange Good Practices and Experiences in Europe" http://www.sunflower-project.eu
  • 2009-2011, Project financed by the European Commission Executive Agency for Health and Consumers, H-CUBE Grant No. 2008207: HBV-HCV-HIV: three different and serious threats for European young people a network to study and face these challenges in the EU
  • 2011-2013, Project PNII-PD23/2011. "Quantitative evaluation of the expression of hepatic transcription factors in hepatocarcinoma: a new prognostic marker for tumor recurrence after curative treatment".
  • 2011–2016, Project PNII–PCE 125/2011. Molecular predictors of prognosis following curative treatment of hepatocellular carcinoma: the significance of liver stem/progenitor cell genes.
  • 2017,Mobility Project PNIII-P1-1.1-MC-2017-2268, Project Director
  • 2018-2022, Management training program for Romanian medical personnel patients chronically infected with hepatitis B and C viruses - HEPATER"
  • Author/Co-author of 16 ISI articles with an impact factor and over 60 papers published at national and international conferences.
Dr. Livadariu Mirela Head of Laboratory, Ponderas Hospital, CMU, Bucharest
  • March 2021–present: Head of Laboratory, Ponderas Hospital, CMU, Bucharest
  • September 2015–March 2021: Medical Director of Medcenter Laboratories, Romania
  • August 2013–August 2015: Medical Director, CBC Laboratories Romania
  • July 2009–August 2015: primary physician in laboratory medicine, Head of laboratory at CBC Laboratories, Cord Blood Center, Bucharest
  • May 2008–June 2009: Primary Physician Laboratory Medicine, Head of Laboratory, S.C. Puls Medica SRL, Bucharest
  • March 2005–April 2008: primary physician laboratory medicine; microbiology department coordinator: S.C. Synevo Romania SRL, Bucharest
  • February 2000–February 2005: laboratory medicine specialist; microbiology department coordinator; S.C. Medicover Rombel SRL, Bucharest
  • February 1998–January 2000: residency in microbiology (bacteriology, parasitology, virology, and immunology) at the Cantacuzino Institute in Bucharest
  • February 1997–January 1998: residency in biochemistry at Fundeni Clinical Institute in Bucharest
  • February 1996–January 1997: residency in hematology at Coltea Clinical Hospital, Bucharest
Dr. Patru Loredana Florina Regional Medical Director, ARENSIA Exploratory Medicine
  • 2020 - present Regional Medical Director , ARENSIA Exploratory Medicine
  • 2011 - present Trial Physician, ARENSIA Exploratory Medicine
  • 2008 - 2010 Qualified Person Responsible with Pharmacovigilance /Medical Advisor, Biofarm

Brief Summary of xperience in Clinical Trials:

  • Phase I trial in Sjogren Syndrome
  • Phase Ib/IIa trial in HBV
  • Phase I/IIa trial in Cystic Fibrosis
  • 4 Phase I trial in Renal Impaired
  • Bioequivalence and Phase I trial in Metastatic Breast Cancer
  • Phase I, Phase II trial in COPD
  • Phase I trial in Ulcerative Colitis
  • Phase I in HIV
  • 2 Phase I trial in Rheumatoid Arthritis
  • Phase II trial in Atopic Dermatitis
  • Phase I trial in Lung Cancer
  • No compound trial in Asthma
  • Phase I trial in Neurology
  • Phase I trial in Hepatic Impaired
  • Phase I/II/III trials in COVID-19
  • Phase I trial in HBV

For previous events, please access one of the following links.